These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32554176)

  • 1. Identification of Novel TRPC5 Inhibitors by Pharmacophore-Based and Structure-Based Approaches.
    Li S; Zhang S; Chen D; Jiang X; Liu B; Zhang H; Rachakunta M; Zuo Z
    Comput Biol Chem; 2020 Jun; 87():107302. PubMed ID: 32554176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel modulators targeting human TRPC5: Docking-based virtual screening, molecular dynamics simulation and binding affinity predication.
    Liu B; Zhang W; Guo S; Zuo Z
    J Mol Graph Model; 2021 Jan; 102():107795. PubMed ID: 33161371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potential novel TRPC5 inhibitors by virtual screening and bioassay.
    Shen M; Li L; Li Y; Gu X; Bai L; Xia C; Xiong W; Zuo Z
    Bioorg Med Chem; 2023 Oct; 94():117477. PubMed ID: 37738708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential ligand- and structure-based virtual screening approach for the identification of potential G protein-coupled estrogen receptor-1 (GPER-1) modulators.
    Khan SU; Ahemad N; Chuah LH; Naidu R; Htar TT
    RSC Adv; 2019 Jan; 9(5):2525-2538. PubMed ID: 35520492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors.
    Poonia P; Sharma M; Jha P; Chopra M
    Mol Divers; 2023 Oct; 27(5):2053-2071. PubMed ID: 36214962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-based pharmacophore modeling of TNF-α to design novel inhibitors using virtual screening and molecular dynamics.
    Jade DD; Pandey R; Kumar R; Gupta D
    J Biomol Struct Dyn; 2022 Mar; 40(4):1702-1718. PubMed ID: 33034255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors by virtual screening.
    Zhou Y; Peng J; Li P; Du H; Li Y; Li Y; Zhang L; Sun W; Liu X; Zuo Z
    Comput Biol Chem; 2019 Feb; 78():306-316. PubMed ID: 30616156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of potential inhibitors for stat3: ligand based 3D pharmacophore, virtual screening, molecular docking, dynamic studies and
    Lakshmanan K; T K P; K Pai SR; Rajagopal K; Byran G
    J Biomol Struct Dyn; 2022; 40(21):11320-11338. PubMed ID: 34463213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lead generation of cysteine based mesenchymal epithelial transition (c-Met) kinase inhibitors: Using structure-based scaffold hopping, 3D-QSAR pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulation.
    Raafat A; Mowafy S; Abouseri SM; Fouad MA; Farag NA
    Comput Biol Med; 2022 Jul; 146():105526. PubMed ID: 35487125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further Exploration of the Benzimidazole Scaffold as TRPC5 Inhibitors: Identification of 1-Alkyl-2-(pyrrolidin-1-yl)-1H-benzo[d]imidazoles as Potent and Selective Inhibitors.
    Sharma S; L Pablo J; Tolentino KT; Gallegos W; Hinman J; Beninato M; Asche M; Greka A; Hopkins CR
    ChemMedChem; 2022 Jul; 17(14):e202200151. PubMed ID: 35557491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice.
    Just S; Chenard BL; Ceci A; Strassmaier T; Chong JA; Blair NT; Gallaschun RJ; Del Camino D; Cantin S; D'Amours M; Eickmeier C; Fanger CM; Hecker C; Hessler DP; Hengerer B; Kroker KS; Malekiani S; Mihalek R; McLaughlin J; Rast G; Witek J; Sauer A; Pryce CR; Moran MM
    PLoS One; 2018; 13(1):e0191225. PubMed ID: 29385160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches.
    Nada H; Lee K; Gotina L; Pae AN; Elkamhawy A
    Comput Biol Med; 2022 Mar; 142():105217. PubMed ID: 35032738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of new small molecule monoamine oxidase-B inhibitors through pharmacophore-based virtual screening, molecular docking and molecular dynamics simulation studies.
    Kumar S; Ayyannan SR
    J Biomol Struct Dyn; 2023; 41(14):6789-6810. PubMed ID: 35983603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Englerin A-sensing charged residues for transient receptor potential canonical 5 channel activation.
    Jeong S; Ko J; Kim M; Park KC; Park EYJ; Kim J; Baik Y; Wie J; Cho AE; Jeon JH; So I
    Korean J Physiol Pharmacol; 2019 May; 23(3):191-201. PubMed ID: 31080350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potent and Selective JAK1 Lead Compounds Through Ligand-Based Drug Design Approaches.
    Babu S; Nagarajan SK; Sathish S; Negi VS; Sohn H; Madhavan T
    Front Pharmacol; 2022; 13():837369. PubMed ID: 35529449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of dual kinase inhibitors of CK2 and GSK3β: combined qualitative and quantitative pharmacophore modeling approach.
    Pardhi T; Vasu K
    J Biomol Struct Dyn; 2018 Jan; 36(1):177-194. PubMed ID: 27960601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereo-selective inhibition of transient receptor potential TRPC5 cation channels by neuroactive steroids.
    Majeed Y; Amer MS; Agarwal AK; McKeown L; Porter KE; O'Regan DJ; Naylor J; Fishwick CW; Muraki K; Beech DJ
    Br J Pharmacol; 2011 Apr; 162(7):1509-20. PubMed ID: 21108630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A greasy business: Identification of a diacylglycerol binding site in human TRPC5 channels by cryo-EM.
    Storch U; Mederos Y Schnitzler M; Gudermann T
    Cell Calcium; 2021 Apr; 97():102414. PubMed ID: 33930818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of new ATAD2 bromodomain inhibitors: the application of combined ligand and structure-based virtual screening.
    Sepehri B; Ghavami R
    SAR QSAR Environ Res; 2017 Dec; 28(12):957-971. PubMed ID: 29191061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based virtual screening of the nociceptin receptor: hybrid docking and shape-based approaches for improved hit identification.
    Daga PR; Polgar WE; Zaveri NT
    J Chem Inf Model; 2014 Oct; 54(10):2732-43. PubMed ID: 25148595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.